Wells Fargo’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
|
|||||
|
2025
Q1 | $2.74M | Sell |
|
|||||
|
2024
Q4 | $3.81M | Sell |
|
|||||
|
2024
Q3 | $4.57M | Sell |
|
|||||
|
2024
Q2 | $11M | Sell |
|
|||||
|
2024
Q1 | $35.3M | Buy |
|
|||||
|
2023
Q4 | $20.2M | Sell |
|
|||||
|
2023
Q3 | $22M | Buy |
|
|||||
|
2023
Q2 | $20.9M | Sell |
|
|||||
|
2023
Q1 | $33.4M | Sell |
|
|||||
|
2022
Q4 | $36.2M | Buy |
|
|||||
|
2022
Q3 | $29.5M | Buy |
|
|||||
|
2022
Q2 | $27.3M | Sell |
|
|||||
|
2022
Q1 | $27.4M | Buy |
|
|||||
|
2021
Q4 | $26.2M | Buy |
|
|||||
|
2021
Q3 | $18.1M | Sell |
|
|||||
|
2021
Q2 | $21.5M | Sell |
|
|||||
|
2021
Q1 | $25.3M | Sell |
|
|||||
|
2020
Q4 | $48.2M | Buy |
|
|||||
|
2020
Q3 | $41M | Sell |
|
|||||
|
2020
Q2 | $139M | Buy |
|
|||||
|
2020
Q1 | $86.1M | Buy |
|
|||||
|
2019
Q4 | $44.1M | Sell |
|
|||||
|
2019
Q3 | $39.5M | Sell |
|
|||||
|
2019
Q2 | $60.7M | Sell |
|
|||||
|
2019
Q1 | $64M | Sell |
|
|||||
|
2018
Q4 | $65.4M | Sell |
|
|||||
|
2018
Q3 | $93.5M | Buy |
|
|||||
|
2018
Q2 | $74.7M | Buy |
|
|||||
|
2018
Q1 | $60.6M | Sell |
|
|||||
|
2017
Q4 | $93.9M | Buy |
|
|||||
|
2017
Q3 | $62.4M | Sell |
|
|||||
|
2017
Q2 | $141M | Sell |
|
|||||
|
2017
Q1 | $167M | Sell |
|
|||||
|
2016
Q4 | $189M | Sell |
|
|||||
|
2016
Q3 | $220M | Sell |
|
|||||
|
2016
Q2 | $195M | Sell |
|
|||||
|
2016
Q1 | $219M | Buy |
|
|||||
|
2015
Q4 | $272M | Buy |
|
|||||
|
2015
Q3 | $169M | Buy |
|
|||||
|
2015
Q2 | $160M | Sell |
|
|||||
|
2015
Q1 | $151M | Sell |
|
|||||
|
2014
Q4 | $173M | Sell |
|
|||||
|
2014
Q3 | $213M | Buy |
|
|||||
|
2014
Q2 | $182M | Sell |
|
|||||
|
2014
Q1 | $237M | Sell |
|
|||||
|
2013
Q4 | $272M | Buy |
|
|||||
|
2013
Q3 | $175M | Sell |
|
|||||
|
2013
Q2 | $138M | Buy |
|